-
Prerna Payal
- Sep 10, 2025
- 6 minutes read
- 120 Views
Russia’s Enteromix cancer vaccine has shown a 100% success rate in its early clinical trials, raising new hopes for cancer treatment. This article explores how the vaccine works, its potential impact, and what lies ahead before it reaches patients.